Q32 Bio (QTTB) Change in Acquisitions & Divestments (2018 - 2024)
Q32 Bio (QTTB) recorded quarterly Change in Acquisitions & Divestments of $10.0 million in Q3 2024, up 0.98% quarter-over-quarter from $9.9 million in Q2 2024.
Q32 Bio (QTTB) Change in Acquisitions & Divestments (2018 - 2024) Analysis & Trends
Q32 Bio's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $10.0 million for Q3 2024.
- In Q3 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $10.0 million; the TTM figure through Jun 2025 stood at $10.0 million (changed 0.0% YoY), while the FY2024 annual figure was $20.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments was $10.0 million for Q3 2024 at Q32 Bio, up from $9.9 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $117.0 million in Q1 2020 to a low of $97000.0 in Q1 2024.
- Historically, Change in Acquisitions & Divestments has averaged $35.8 million across 4 years, with a median of $28.5 million in 2020.
- The sharpest annual moves came in 2020 and 2022: Change in Acquisitions & Divestments rose 2.12% in 2020, then slumped 59.09% in 2022.
- A 4-year view of Change in Acquisitions & Divestments shows it stood at $39.0 million in 2020, then climbed by 12.82% to $44.0 million in 2021, then plunged by 59.09% to $18.0 million in 2022, then slumped by 44.44% to $10.0 million in 2024.
- The last three Change in Acquisitions & Divestments figures came in at $10.0 million (Q3 2024), $9.9 million (Q2 2024), and $97000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Mar 31, 2024 | 97,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Dec 31, 2022 | 18.00 Mn |
| Dec 31, 2022 | 18.00 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Mar 31, 2022 | 39.46 Mn |
| Mar 31, 2022 | 39.46 Mn |
| Dec 31, 2021 | 44.00 Mn |
| Dec 31, 2021 | 44.00 Mn |
| Sep 30, 2020 | 39.00 Mn |
| Sep 30, 2020 | 39.00 Mn |
| Jun 30, 2020 | 72.59 Mn |
| Jun 30, 2020 | 72.59 Mn |
| Mar 31, 2020 | 117.03 Mn |
| Mar 31, 2020 | 117.03 Mn |